
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.410 | 100.410 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.813 | 17.601 |
Price to Book | 2.544 | 3.969 |
Price to Sales | 3.782 | 4.887 |
Price to Cash Flow | 8.094 | 14.123 |
Dividend Yield | 0.332 | 0.524 |
5 Years Earnings Growth | 1.864 | 8.046 |
Number of long holdings: 40
Number of short holdings: 20
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ionis Pharma | US4622221004 | 9.76 | 70.74 | +1.11% | |
Biogen | US09062X1037 | 9.65 | 149.36 | -1.07% | |
Alnylam | US02043Q1076 | 5.52 | 455.75 | +1.13% | |
Swedish Orphan Biovitrum | SE0000872095 | 4.95 | 305.00 | -2.31% | |
Crispr Therapeutics | CH0334081137 | 4.87 | 75.94 | -1.10% | |
Jazz Pharma | IE00B4Q5ZN47 | 4.74 | 138.10 | +0.23% | |
Alkermes Plc | IE00B56GVS15 | 4.55 | 31.72 | +0.67% | |
Gilead | US3755581036 | 4.47 | 117.02 | -1.04% | |
Regeneron Pharma | US75886F1075 | 4.45 | 568.90 | +0.89% | |
Incyte | US45337C1027 | 4.40 | 85.06 | -0.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class A | 79.84M | 3.50 | -9.61 | 2.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review